Tackling the world’s biggest problems
is not only an ethical necessity,
it’s an unprecedented financial opportunity.
Because impact can drive profit, we use a rigorous quantitative method to identify the top 1% most impactful startups. We maximise that impact by offering active support to founders and by investing when we make the biggest difference: early stage and in technologies or geographies underserved by other investors.
Accelerating innovation, public momentum, and the shift to abundant renewable energy are enabling entirely new business models. These business models don’t compromise profitability for impact, but are profitable because of their impact.
We are dedicated to investing in transformative companies tackling climate change, poverty, and healthcare challenges. Our mission is to support innovative startups that create lasting impact globally, fostering a sustainable and prosperous future for all.
Portfolio
Companies with outlier impact in climate, poverty reduction, or healthcare.
Leveraging Kenya’s unique geological properties to sequester CO2 from air and store it underground.
Invested: pre-seed + seed
Kenya
Planet- and animal-friendly dairy proteins, produced in plants.
Invested: pre-seed
South Africa
Restoring smallholder farmland and sequestering carbon at scale by producing biochar based fertilizer.
Invested: pre-seed
Kenya
Connecting deeply remote rural areas in Africa to the world of digital health.
Invested: seed
Uganda
AI co-pilot for chemical process optimization in drug development.
Invested: pre-seed
United Kingdom
Solving retail logistics for the most deeply remote areas in Africa.
Invested: pre-seed + seed
Kenya
Unlocking cell regeneration to combat chronic diseases like diabetes and cancer.
Invested: seed
South Africa, United States
Restoring the ocean's natural capacity to capture and permanently store CO2.
Invested: pre-seed
France
Transforming food industry side streams into sustainable high-value ingredients.
Invested: seed
Norway, Japan
Next-generation mRNA technologies, vaccines and therapies that augment the immune system
Invested: series A
United States
